{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:51:59Z","timestamp":1761630719029},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.endonu.2015.01.011","type":"journal-article","created":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T13:34:45Z","timestamp":1427549685000},"page":"e47-e56","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Actualizaci\u00f3n de las recomendaciones para la evaluaci\u00f3n y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales. Grupo de trabajo de osteoporosis y metabolismo mineral de la SEEN"],"prefix":"10.1016","volume":"62","author":[{"given":"Rebeca","family":"Reyes-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Garc\u00eda-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariela","family":"Varsavsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Rozas-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Cort\u00e9s-Berdonces","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e9s","family":"Luque-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"G\u00f3mez S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Vidal Casariego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Romero Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonsoles","family":"Guadalix Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Fern\u00e1ndez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"J\u00f3dar Gimeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Mu\u00f1oz Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endonu.2015.01.011_bib0300","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.endonu.2012.01.002","article-title":"Gu\u00edas de pr\u00e1ctica cl\u00ednica para la evaluaci\u00f3n y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales","volume":"59","author":"Reyes Garc\u00eda","year":"2012","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.endonu.2015.01.011_bib0305","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.endonu.2015.01.011_bib0310","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Endocrine Society Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0315","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.4321\/S1889-836X2014000500004","article-title":"Recomendaciones sobre como administrar la vitamina D. Gu\u00edas nacionales e internacionales","volume":"6","author":"J\u00f3dar Gimeno","year":"2014","journal-title":"Rev Osteoporos Metab Miner"},{"key":"10.1016\/j.endonu.2015.01.011_bib0320","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/dmrr.2508","article-title":"Association between bone mineral density and type 1 diabetes mellitus: A meta-analysis of cross-sectional studies","volume":"30","author":"Pan","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.endonu.2015.01.011_bib0325","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.diabres.2013.12.018","article-title":"Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes","volume":"103","author":"Loureiro","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.endonu.2015.01.011_bib0330","doi-asserted-by":"crossref","first-page":"397814","DOI":"10.1155\/2013\/397814","article-title":"A study of bone mineral density and its determinants in type 1 diabetes mellitus","volume":"2013","author":"Joshi","year":"2013","journal-title":"J Osteoporos"},{"key":"10.1016\/j.endonu.2015.01.011_bib0335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1472-6823-14-33","article-title":"Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus","volume":"14","author":"Leidig-Bruckner","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.endonu.2015.01.011_bib0340","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2337\/dc12-1355","article-title":"Prevalence of morphometric vertebral fractures in patients with type 1 diabetes","volume":"36","author":"Zhukouskaya","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endonu.2015.01.011_bib0345","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00198-014-2631-7","article-title":"High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control","volume":"25","author":"Neumann","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.endonu.2015.01.011_bib0350","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.ajem.2013.12.055","article-title":"Thoracic spine fracture in the course of severe nocturnal hypoglycemia in young patients with type 1 diabetes mellitus--the role of low bone mineral density","volume":"32","author":"Majkowska","year":"2014","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.endonu.2015.01.011_bib0355","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","article-title":"Association between bone mineral density and type 2 diabetes mellitus: A meta-analysis of observational studies","volume":"27","author":"Ma","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.endonu.2015.01.011_bib0360","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","article-title":"Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus","volume":"97","author":"Garc\u00eda-Mart\u00edn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0365","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s00774-013-0548-4","article-title":"Homocysteine an additional factor, is linked to osteoporosis in postmenopausal women with type 2 diabetes","volume":"32","author":"Jianbo","year":"2014","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0370","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2012-4018","article-title":"Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus","volume":"98","author":"Bilezikian","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0375","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00198-014-2704-7","article-title":"Bone quality assessment in type 2 diabetes mellitus","volume":"25","author":"Dhaliwal","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.endonu.2015.01.011_bib0380","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/jc.2012-3118","article-title":"Manitoba Bone Density Program TBS (trabecular bone score) and diabetes-related fracture risk","volume":"98","author":"Leslie","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0385","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1210\/jc.2014-2047","article-title":"Trabecular bone score as an indicator for skeletal deterioration in diabetes","volume":"100","author":"Kim","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0390","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/jdi.12034","article-title":"Ischemic heart disease is associated with vertebral fractures in patients with type 2 diabetes mellitus","volume":"4","author":"Mu\u00f1oz-Torres","year":"2013","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.endonu.2015.01.011_bib0395","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2265.2011.04222.x","article-title":"Diabetic peripheral neuropathy is highly associated with nontraumatic fractures in Korean patients with type 2 diabetes mellitus","volume":"77","author":"Kim","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endonu.2015.01.011_bib0400","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00774-012-0398-5","article-title":"The prevalence and risk factors of vertebral fractures in Korean patients with type 2 diabetes","volume":"31","author":"Chung","year":"2013","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0405","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1210\/jc.2013-2143","article-title":"Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus","volume":"98","author":"Yamamoto","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0410","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bone.2013.06.029","article-title":"Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes","volume":"56","author":"Ardawi","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.endonu.2015.01.011_bib0415","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1507\/endocrj.EJ12-0269","article-title":"The association of serum 25-hydroxyvitamin D and vertebral fractures in patients with type 2 diabetes","volume":"60","author":"Kim","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.endonu.2015.01.011_bib0420","doi-asserted-by":"crossref","unstructured":"Hwang YC.The Association between Serum Endogenous Secretory Receptor for Advanced Glycation End Products and Vertebral Fractures in Type 2 Diabetes. Endocrinol Metab. 2013;28:76-7.","DOI":"10.3803\/EnM.2013.28.1.76"},{"key":"10.1016\/j.endonu.2015.01.011_bib0425","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jbmr.556","article-title":"FRAX underestimates fracture risk in patients with diabetes","volume":"27","author":"Giangregorio","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.endonu.2015.01.011_bib0430","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s00198-014-2822-2","article-title":"Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?","volume":"25","author":"Leslie","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.endonu.2015.01.011_bib0435","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/jbmr.1759","article-title":"Type 2 diabetes and bone","volume":"27","author":"Leslie","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.endonu.2015.01.011_bib0440","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: Proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0445","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jc.2014-2000","article-title":"The surgical management of asymptomatic primary hyperparathyroidism: Proceedings of the Fourth International Workshop","volume":"99","author":"Udelsman","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0450","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: Proceedings of the Fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0455","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0460","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2013-3978","article-title":"Vitamin D treatment in primary hyperparathyroidism: A randomized controlled trial","volume":"99","author":"Rolighed","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0465","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pds.2258","article-title":"Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States","volume":"21","author":"Beebe-Dimmer","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.endonu.2015.01.011_bib0470","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1464-410X.2012.11758.x","article-title":"Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications","volume":"111","author":"Shao","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.endonu.2015.01.011_bib0475","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/pcan.2011.4","article-title":"Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: A systematic review and meta-analysis","volume":"15","author":"Serpa Neto","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.endonu.2015.01.011_bib0480","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s10549-012-2013-9","article-title":"Vitamin D threshold to prevent aromatase inhibitor-related bone loss: The B-ABLE prospective cohort study","volume":"133","author":"Prieto-Alhambra","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.endonu.2015.01.011_bib0485","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/EJE-12-0070","article-title":"A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: A KIMS database analysis","volume":"16","author":"Tritos","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.01.011_bib0490","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/EJE-11-1072","article-title":"Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency","volume":"166","author":"Elbornsson","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.01.011_bib0495","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00774-005-0649-9","article-title":"Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function","volume":"24","author":"Bolanowski","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0500","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2265.1998.00349.x","article-title":"Gonadal status is an important determinant of bone density in acromegaly","volume":"48","author":"Lesse","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endonu.2015.01.011_bib0505","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2265.2003.01777.x","article-title":"Bone mineral density in acromegaly: The effect of gender, disease activity and gonadal status","volume":"58","author":"Scillitani","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endonu.2015.01.011_bib0510","first-page":"621","article-title":"In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender","volume":"28","author":"Zgliczynski","year":"2007","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.endonu.2015.01.011_bib0515","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/eje.1.02285","article-title":"IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: A prospective study of more than 70 consecutive patients","volume":"155","author":"Ueland","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.01.011_bib0520","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1210\/jc.2012-4073","article-title":"Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography","volume":"98","author":"Madeira","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0525","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2362.2002.00944.x","article-title":"Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly","volume":"32","author":"Ueland","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.endonu.2015.01.011_bib0530","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1210\/jc.2014-2937","article-title":"Bone turnover, bone mineral density and fracture risk in acromegaly: A meta-analysis","volume":"100","author":"Mazziotti","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0535","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1359\/JBMR.050603","article-title":"Increased prevalence of radiological spinal deformities in active acromegaly: A cross-sectional study in postmenopausal women","volume":"20","author":"Bonadonna","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.endonu.2015.01.011_bib0540","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/EJE-10-1005","article-title":"High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly","volume":"164","author":"Wassenaar","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.01.011_bib0545","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2008-0791","article-title":"Prevalence of vertebral fractures in men with acromegaly","volume":"93","author":"Mazziotti","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0550","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1210\/jc.2013-1460","article-title":"Vertebral fractures in patients with acromegaly: A 3-year prospective study","volume":"98","author":"Mazziotti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0555","first-page":"37","article-title":"Prevalence of osteoporosis and vertebral fractures in acromegalic patients","volume":"8","author":"Padova","year":"2011","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0560","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1210\/jc.2013-2695","article-title":"Progression of vertebral fractures despite long-term biochemical control of acromegaly: A prospective follow-up study","volume":"98","author":"Claessen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.01.011_bib0565","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-003-1531-z","article-title":"Fracture risk is decreased in acromegaly-a potential beneficial effect of growth hormone","volume":"15","author":"Vestergaard","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.endonu.2015.01.011_bib0570","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40618-014-0126-1","article-title":"Fracture risk assessment before and after resolution of endogenous hypercortisolism: Is the FRAX\u00ae algorithm useful?","volume":"37","author":"Trementino","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.endonu.2015.01.011_bib0575","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00198-013-2588-y","article-title":"Treatment of skeletal impairment in patients with endogenous hypercortisolism: When and how?","volume":"25","author":"Scillitani","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.endonu.2015.01.011_bib0580","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2796.2011.02352.x","article-title":"Risk of hip fracture in Addison's disease: A population-based cohort study","volume":"270","author":"Bj\u00f6rnsdottir","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.endonu.2015.01.011_bib0585","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cgh.2013.08.024","article-title":"Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: A meta-analysis and systematic review","volume":"12","author":"Melek","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.endonu.2015.01.011_bib0590","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/jbmr.447","article-title":"Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa","volume":"26","author":"Misra","year":"2011","journal-title":"J Bone Miner Res"}],"container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157509221500056X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157509221500056X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:22:02Z","timestamp":1537748522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157509221500056X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S157509221500056X"],"URL":"https:\/\/doi.org\/10.1016\/j.endonu.2015.01.011","relation":{},"ISSN":["1575-0922"],"issn-type":[{"value":"1575-0922","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualizaci\u00f3n de las recomendaciones para la evaluaci\u00f3n y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales. Grupo de trabajo de osteoporosis y metabolismo mineral de la SEEN","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endonu.2015.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 SEEN. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}